Edinburgh Research Explorer

Yanick Crow

Chair of Genomic Medicine

  1. 2017
  2. Type I interferon-mediated autoinflammation due to DNase II deficiency

    Rodero, M. P., Tesser, A., Bartok, E., Rice, G. I., Della Mina, E., Depp, M., Beitz, B., Bondet, V., Cagnard, N., Duffy, D., Dussiot, M., Frémond, M., Gattorno, M., Guillem, F., Kitabayashi, N., Porcheray, F., Rieux-laucat, F., Seabra, L., Uggenti, C., Volpi, S. & 37 others, Zeef, L. A. H., Alyanakian, M., Beltrand, J., Bianco, A. M., Boddaert, N., Brouzes, C., Candon, S., Caorsi, R., Charbit, M., Fabre, M., Faletra, F., Girard, M., Harroche, A., Hartmann, E., Lasne, D., Marcuzzi, A., Neven, B., Nitschke, P., Pascreau, T., Pastore, S., Picard, C., Picco, P., Piscianz, E., Polak, M., Quartier, P., Rabant, M., Stocco, G., Taddio, A., Uettwiller, F., Valencic, E., Vozzi, D., Hartmann, G., Barchet, W., Hermine, O., Bader-meunier, B., Tommasini, A. & Crow, Y. J., 19 Dec 2017, In : Nature Communications. 8, 1, p. 2176

    Research output: Contribution to journalArticle

  3. Musculoskeletal Disease in MDA5-Related Type I Interferonopathy: A Mendelian Mimic of Jaccoud's Arthropathy: MUSCULOSKELETAL DISEASE IN MDA-5-RELATED TYPE I INTERFERONOPATHY

    De Carvalho, L. M., Ngoumou, G., Park, J. W., Ehmke, N., Deigendesch, N., Kitabayashi, N., Melki, I., Souza, F. F. L., Tzschach, A., Nogueira-barbosa, M. H., Ferriani, V., Louzada-junior, P., Marques, W., Lourenço, C. M., Horn, D., Kallinich, T., Stenzel, W., Hur, S., Rice, G. I. & Crow, Y. J., 1 Oct 2017, In : Arthritis & Rheumatology. 69, 10, p. 2081-2091

    Research output: Contribution to journalArticle

  4. Modeling of TREX1-Dependent Autoimmune Disease using Human Stem Cells Highlights L1 Accumulation as a Source of Neuroinflammation

    Thomas, C. A., Tejwani, L., Trujillo, C. A., Negraes, P. D., Herai, R. H., Mesci, P., Macia, A., Crow, Y. J. & Muotri, A. R., 7 Sep 2017, In : Cell Stem Cell. 21, 3, p. 319-331.e8

    Research output: Contribution to journalArticle

  5. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling

    Melki, I., Rose, Y., Uggenti, C., Van Eyck, L., Frémond, M., Kitabayashi, N., Rice, G. I., Jenkinson, E. M., Boulai, A., Jeremiah, N., Gattorno, M., Volpi, S., Sacco, O., Terheggen-lagro, S. W. J., Tiddens, H. A. W. M., Meyts, I., Morren, M., De Haes, P., Wouters, C., Legius, E. & 6 others, Corveleyn, A., Rieux-laucat, F., Bodemer, C., Callebaut, I., Rodero, M. P. & Crow, Y. J., 1 Aug 2017, In : Journal of Allergy and Clinical Immunology. 140, 2, p. 543-552.e5

    Research output: Contribution to journalArticle

  6. Brief Report: Blockade of TANK-Binding Kinase 1/IKKɛ Inhibits Mutant Stimulator of Interferon Genes (STING)-Mediated Inflammatory Responses in Human Peripheral Blood Mononuclear Cells

    Frémond, M., Uggenti, C., Van Eyck, L., Melki, I., Bondet, V., Kitabayashi, N., Hertel, C., Hayday, A., Neven, B., Rose, Y., Duffy, D., Crow, Y. J. & Rodero, M. P., Jul 2017, In : Arthritis & Rheumatology. 69, 7, p. 1495-1501 7 p.

    Research output: Contribution to journalArticle

  7. Polymorphisms in IFIH1: the good and the bad

    Della Mina, E., Rodero, M. P. & Crow, Y. J., 20 Jun 2017, In : Nature Immunology. 18, 7, p. 708-709 2 p.

    Research output: Contribution to journalArticle

  8. Genetic, Phenotypic, and Interferon Biomarker Status in ADAR1-Related Neurological Disease

    Rice, G., Kitabayashi, N., Barth, M., Briggs, T., Burton, A., Carpanelli, M., Cerisola, A., Colson, C., Dale, R., Danti, F., Darin, N., De Azua, B., De Giorgis, V., De Goede, C., Desguerre, I., De Laet, C., Eslahi, A., Fahey, M., Fallon, P., Fay, A. & 32 others, Fazzi, E., Gorman, M., Gowrinathan, N., Hully, M., Kurian, M., Leboucq, N., Lin, J., Lines, M., Mar, S., Maroofian, R., Martí-sanchez, L., Mccullagh, G., Mojarrad, M., Narayanan, V., Orcesi, S., Ortigoza-escobar, J., Pérez-dueñas, B., Petit, F., Ramsey, K., Rasmussen, M., Rivier, F., Rodríguez-pombo, P., Roubertie, A., Stödberg, T., Toosi, M., Toutain, A., Uettwiller, F., Ulrick, N., Vanderver, A., Waldman, A., Livingston, J. & Crow, Y., 1 Jun 2017, In : Neuropediatrics. 48, 03, p. 166-184

    Research output: Contribution to journalArticle

  9. Treatment of Leukoencephalopathy With Calcifications and Cysts With Bevacizumab

    Fay, A. J., King, A. A., Shimony, J. S., Crow, Y. J. & Brunstrom-Hernandez, J. E., 1 Jun 2017, In : Pediatric Neurology. 71, p. 56-59 4 p.

    Research output: Contribution to journalArticle

  10. MDA5-Associated Neuroinflammation and the Singleton-Merten Syndrome: Two Faces of the Same Type I Interferonopathy Spectrum

    Buers, I., Rice, G. I., Crow, Y. J. & Rutsch, F., May 2017, In : Journal of Interferon and Cytokine Research. 37, 5, p. 214-219 6 p.

    Research output: Contribution to journalReview article

  11. Detection of interferon alpha protein reveals differential levels and cellular sources in disease

    Rodero, M. P., Decalf, J., Bondet, V., Hunt, D., Rice, G. I., Werneke, S., McGlasson, S. L., Alyanakian, M-A., Bader-Meunier, B., Barnerias, C., Bellon, N., Belot, A., Bodemer, C., Briggs, T. A., Desguerre, I., Frémond, M-L., Hully, M., van den Maagdenberg, A. MJM., Melki, I., Meyts, I. & 15 others, Musset, L., Pelzer, N., Quartier, P., Terwindt, G. M., Wardlaw, J., Wiseman, S., Rieux-Laucat, F., Rose, Y., Neven, B., Hertel, C., Hayday, A., Albert, M. L., Rozenberg, F., Crow, Y. J. & Duffy, D., 18 Apr 2017, In : Journal of Experimental Medicine.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 ...10 Next